Skip to content

Depression: all studies

Page 254 of 1,040: studies 2,531 to 2,540 of 10,391, newest first. Back to the depression overview

Research

A Study Evaluating Mindfulness and Naikan-Based Therapy: AEON-HO for Attachment Style, Self-Actualization, and Depression

Psychological Reports April 1, 2020 Chieko Fujisaki

AEON-HO (Altering emotional organization-holistic operation) contains methods of Naikan therapy and mindfulness. Naikan and mindfulness are originally from Buddhism tradition, and they have a high affinity. AEON-HO was conceptualized to improve attachment issues and the growth of self-actualization, because Naikan and mindfulness are known to be effective for attachment issues but partially if...

144 Esketamine Nasal Spray for Management of Treatment-Resistant Depression: Number Needed to Treat, Number Needed to Harm, Likelihood to be Helped/Harmed

CNS Spectrums April 1, 2020 Leslie Citrome, Allitia DiBernardo, Jaskaran Singh

Abstract: Background: Targeting of glutamate receptors is a novel approach for the treatment of major depressive disorder (MDD). This study aimed to review the usefulness for esketamine nasal spray for the management of treatment-resistant depression (TRD) using the tools of evidence-based medicine: number needed to treat (NNT), number needed to harm (NNH), and likelihood to be helped or harmed...

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review

Frontiers in Psychiatry March 31, 2020 Kristin Heuschkel, Kim P. C. Kuypers 82 citations

Depression is a major public health problem that affects approximately 4.4% of the global population. Since conventional pharmacotherapies and psychotherapies are only partially effective, as demonstrated by the number of patients failing to achieve remission, alternative treatments are needed. Mindfulness meditation (MM) and psilocybin represent two promising novel treatments that might even...

Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.

Psychiatry Research March 6, 2020 Jianjing Zhang, H. Tian, Jie Li et al. 13 citations

New methods for using ketamine in patients with propofol-electroconvulsive therapy-resistant depression (ECT-RD) are needed in the clinic. This study aimed to investigate the therapeutic efficacy of ketamine plus ECT in ECT-RD patients, along with the treatment-induced brain alterations. A total of 28 ECT-RD patients were intravenously injected with ketamine six times and treated with...

Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression

ACS Chemical Neuroscience March 5, 2020 Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer et al. 211 citations

Psilocybin shows efficacy to alleviate depression in human clinical trials for six or more months after only one or two treatments. Another hallucinogenic drug, esketamine, has recently been U.S. Food and Drug Administration (FDA)-approved as a rapid-acting antidepressant. The mechanistic basis for the antidepressant effects of psilocybin and ketamine appear to be conserved. The efficacy of...

Mindfulness and nocturnal rumination are independently associated with symptoms of insomnia and depression during pregnancy.

Sleep Health March 4, 2020 David A Kalmbach, Thomas Roth, P. Cheng et al.

BACKGROUND Insomnia and depression are highly prevalent perinatal complications. Ruminating on stress is etiologically implicated in both disorders, and ruminating while trying to fall asleep has been linked to insomnia and depression during pregnancy. Incompatible with rumination is everyday mindfulness, i.e., living with intentional and nonjudgmental awareness of internal and external...

The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.

Journal of Affective Disorders March 1, 2020 David S. Mathai, Matthew Meyer, Eric A. Storch et al.

The relationship between ketamine's hallucinogenic- and dissociative-type effects and antidepressant mechanism of action is poorly understood. This paper reviewed the correlation between subjective effects defined by various psychometric scales and observed clinical outcomes in the treatment of patients with Major Depressive Disorder (MDD). Based on PRISMA guidelines, we reviewed the...

Effects of mindfulness meditation on anxiety, depression, stress, and mindfulness in nursing students: a meta-analysis and trial sequential analysis of randomized controlled trials

Frontiers of Nursing March 1, 2020 Yu-feng Li, Wenxiang Sun, Xiu-Jie Sun et al.

Abstract Objective The aim of this study was to assess the effectiveness of mindfulness meditation (MM) on anxiety, depression, stress and mindfulness in nursing students. Methods A comprehensive search and screening procedures were conducted to locate all MM interventions implemented with nursing students. For randomized controlled trials (RCTs) in accordance with the inclusion criteria, a...

Implementation of a mindfulness-based stress reduction (MBSR) program to reduce stress, anxiety, and depression and to improve psychological well-being among retired Iranian football players

Psychology of Sport And Exercise March 1, 2020 Ebrahim Norouzi, Markus Gerber, Frough Fattahi Masrour et al.

Abstract Objectives To test whether a mindfulness-based stress reduction (MBSR) program could reduce symptoms of anxiety, stress, and depression, and increase psychological well-being among retired Iranian football players compared to an active control group. Design Randomized controlled trial, with an 8-week MBSR intervention (16 group sessions, 90 min each) and an active control group. Three...

DEPRESSION MANAGEMENT VIA VIPASSANA MEDITATION AMONG GREY- COLLAR WORKERS

February 29, 2020 N. Gupta

Dr. Neeta Gupta Department of Psychology, DAV(PG) College, Dehradun. ...................................................................................................................... Manuscript Info Abstract ......................... ........................................................................ Manuscript History Received: 17 December 2019 Final Accepted: 20 January 2020...